ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,213,976, issued on Feb. 4, was assigned to OxaluRx Inc. (Saint Louis, Mo.).
"Compounds and methods for treating oxalate-related diseases" was invented by Ayman Kabakibi (San Diego), Mehmet Kahraman (La Jolla, Calif.), Michael Clare (Skokie, Ill.) and Thomas Leedom (Escondido, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds and compositions for modulating glycolate oxidase, useful for treating oxalate-related diseases, such as hyperoxaluria, where modulating glycolate oxidase is expected to be therapeutic to a patent in need thereof. Methods of modulating glycolate oxidase activity in a human or animal subject are also...